Cabazitaxel-Loaded Nanoparticles Reduce the Invasiveness in Metastatic Prostate Cancer Cells: Beyond the Classical Taxane Function.

Cabazitaxel-Loaded Nanoparticles Reduce the Invasiveness in Metastatic Prostate Cancer Cells: Beyond the Classical Taxane Function.
复制标题

DOI:
10.3390/pharmaceutics15020662
复制
发表时间:
2023-02-16
期刊:
影响因子:
5.4
通讯作者:
Vishwanatha JK
Vishwanatha JK
中科院分区:
医学2区
文献类型:
--
作者:
Lampe JB;Desai PP;Tripathi AK;Sabnis NA;Chen Z;Ranjan AP;Vishwanatha JK

文献摘要

参考文献

被引文献

相似文献

Bone-metastatic prostate cancer symbolizes the beginning of the later stages of the disease. We designed a cabazitaxel-loaded, poly (lactic-co-glycolic acid) (PLGA) nanoparticle using an emulsion-diffusion-evaporation technique. Bis (sulfosuccinimidyl) suberate (BS3) was non-covalently inserted into the nanoparticle as a linker for the conjugation of a bone-targeting moiety to the outside of the nanoparticle. We hypothesized that the nanoparticles would have the ability to inhibit the epithelial-to-mesenchymal transition (EMT), invasion, and migration in prostate cancer cells. Targeted, cabazitaxel-loaded nanoparticles attenuated the EMT marker, Vimentin, and led to an increased E-cadherin expression. These changes impart epithelial characteristics and inhibit invasive properties in cancer progression. Consequently, progression to distant sites is also mitigated. We observed the reduction of phosphorylated Src at tyrosine 416, along with increased expression of phosphorylated cofilin at serine 3. These changes could affect migration and invasion pathways in cancer cells. Both increased p-120 catenin and inhibition in IL-8 expression were seen in targeted, cabazitaxel-loaded nanoparticles. Overall, our data show that the targeted, cabazitaxel-loaded nanoparticles can act as a promising treatment for metastatic prostate cancer by inhibiting EMT, invasion, and migration, in prostate cancer cells.
DOI: 10.1016/j.bioadv.2022.213039
发表时间: 2022-07-28
影响因子: --
作者:
Iqbal, Haroon;Razzaq, Anam;Menaa, Farid
通讯作者: Menaa, Farid
DOI: 10.1158/1541-7786.mcr-19-0595
发表时间: 2020-01-01
影响因子: 5.2
作者:
Maynard, Janielle P.;Ertunc, Onur;Sfanos, Karen S.
通讯作者: Sfanos, Karen S.
DOI: 10.18632/oncotarget.10798
发表时间: 2016-08-23
期刊: Oncotarget
影响因子: --
作者:
Kpetemey M;Chaudhary P;Van Treuren T;Vishwanatha JK
通讯作者: Vishwanatha JK
DOI: 10.1056/nejmoa1911206
发表时间: 2019-12-26
影响因子: 158.5
作者:
de Wit, Ronald;de Bono, Johann;Castellano, Daniel
通讯作者: Castellano, Daniel
DOI: 10.3390/cancers10070218
发表时间: 2018-06-27
期刊: Cancers
影响因子: 5.2
作者:
Maurizi A;Rucci N
通讯作者: Rucci N